NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

Change Proposal Summary Report 

The main thing of this administrative summary report is to propose a change in the operation of supplemental neuropathy in diabetic cases in healthcare associations within Colorado. To achieve this, a detailed study of supplemental neuropathy is conducted, along with a comparative analysis of its management in non-U.S. healthcare systems to identify effective measures and strategies for improving health outcomes in people with diabetes by reducing complications associated with supplemental neuropathy.

Executive Summary 

Proposed Change 

Peripheral neuropathy is a grueling complication for cases with diabetes. It affects supplemental jitters, causing pain, sensitive loss, and paresthesia. Diabetic supplemental neuropathy (DPN) impacts 50% of diabetics, resulting in pain with a threat of foot ulcers in 25%, which can lead to leg amputation (Hicks & Selvin, 2019). Considering these consequences of poor care, emphatic sweats are needed to promote aggressive webbing and the operation of diabetes through regular HbA1c monitoring, bottom examination, and pain surgery.

The original healthcare systems in Colorado have been facing supplemental neuropathy as a rising problem for diabetics, where numerous cases suffer from impassiveness in their bases, pain, bottom ulcers, and leg amputations. Given the concerning nature of diabetic supplemental neuropathy and its impact on patients’ quality of life, it is essential to focus on improving this specific area of care so that individuals with diabetes can achieve better health outcomes. By addressing this specific issue and perfecting diabetes operations through acceptable bottom examinations at least formally annually, as recommended by the American Diabetes Association, supplemental neuropathy can be controlled (American Diabetes Association Professional Practice Committee, 2021). Likewise, perfecting glycemic situations through life revision and pharmacotherapy can reduce the threat of supplemental neuropathy and its progression. Furthermore, educating the cases on bottom care and tone-care actions to regulate glycemic situations will enable the delayed onset of supplemental neuropathy (Alahakoon et al., 2020).

Desired Outcomes 

This offer aims to enhance diabetes management for cases with supplemental neuropathy by promoting proper foot examination, foot care, and patient education, addressing several key issues we seek to resolve through this initiative. These asked issues are as follows:

• Prevention of neuropathy complications By timely managing diabetes and supplemental neuropathy, one can help complications similar to infections, delayed mending, bottom ulcerations, and leg amputations in advanced cases of supplemental neuropathy (Selvarajah et al., 2019).
• Enhanced sensation In supplemental neuropathy, the sensitive nerve fibers are damaged, which affects the ability to sense temperature, pain, and pressure, leading to numbness and tingling. By improving glycemic levels and preventing supplemental neuropathy, diabetics can experience heightened sensitivity to changes in physical stimuli that help prevent injuries (Agarwal et al., 2019).
• Advanced mobility and preservation of branch function Managing and precluding supplemental neuropathy through life revision and salutary changes to regulate glycemic situations promotes mobility in people with diabetes and helps them balance and coordinate their gait while walking, which can be hindered by lower whim-whams power. Better mobility will help with pitfalls of case falls and help people with diabetes stay active in their continuance (Zilliox & Russell, 2019).

NURS FPX 6218 Assessment 1 Proposing Evidence-Based Change 

Achieving these issues requires stakeholders to pay for care and apply the requested changes. To achieve this, healthcare associations must have sufficient resources to provide attentive care to people with diabetes suffering from supplemental neuropathy, ensuring that proper baseline examinations are conducted and that nurses assist patients in managing their blood glucose levels. Also, external coffers similar to the Medicare and Medicaid programs of the Affordable Care Act that provide health insurance content for aged people with habitual conditions and promote care delivery to low-income individuals are also implicit sources (Duru et al., 2020).

Some factors that limit the success of these issues include the need for additional ethical and financial resources, as well as insufficient interprofessional collaboration and patient compliance. To achieve optimal healthcare outcomes, it is essential to enforce interprofessional collaboration in delivering patient-centered care for diabetes management and to train doctors and nurses on properly conducting foot examinations. Furthermore, furnishing effective bottom care to avoid long-term complications of supplemental neuropathy is imperative (Aalaa et al., 2022).

Health Care System Comparative Analysis 

We’ve conducted a relative analysis on managing and precluding supplemental neuropathy in two non-U.S. healthcare systems to gain broader knowledge and identify a better approach. The National Health Service (NHS) healthcare system in the United Kingdom follows the guidelines handed down by the National Institute for Health and Care Excellence (NICE), specifically about managing diabetes and associated complications of supplemental neuropathy. NICE recommends that healthcare associations conduct regular foot examinations and promote patient education in people with diabetes on a one-operation and one-care basis to help supplemental neuropathy and the associated complications (NICE, 2019). NICE provides guidelines on the frequency of bottom assessment for all age groups with diabetes, substantially focusing on grown-ups with diabetes to assess based on opinion and periodic checks or when bottom problems arise.

NURS FPX 6218 Assessment 1 Proposing Evidence-Based Change 

Likewise, it guides the disquisition and treatment of foot ulcers, infections, and Charcot arthropathy. Another precious healthcare system grounded in Australia follows the guidelines from the Australian Diabetes Society (Advertisements), which has a particular division on diabetes based in Australia (DFA). It provides comprehensive guidelines and strategies to manage foot care in diabetic cases. DFA offers educational webinars and events on foot care and preventative measures to delay supplemental neuropathy. Likewise, it has lately launched digital DFA guidelines platforms where cases with diabetes can take guidelines for bottom care digitally and daily bottom care rosters (Diabetes Bases Australia, n.d.).

These two non-US-based health approaches towards supplemental neuropathy can guide the US healthcare system in enforcing analogous strategies to help with bottom complications due to supplemental neuropathy. In the original healthcare systems of Colorado, periodic foot examinations for diabetics must be conducted, and croakers must be trained on assessing foot conditions to provide applicable and timely care treatments. Also, the US-grounded healthcare systems can develop educational events on foot care for people with diabetes to enhance their knowledge on supplemental neuropathy and the significance of foot care as created by Australian healthcare systems.

The Rationale for the Proposed Change

These specific proposed changes can ameliorate issues in diabetic cases in terms of supplemental neuropathy. By implementing acceptable methods for preventing and managing supplemental neuropathy, as directed by NICE guidelines and DFA recommendations, individuals with diabetes will experience a longer lifespan with full mobility and the ability to engage in physical activities, as their supplemental symptoms remain stable. Furthermore, lower branch amputation will be averted as the regular monitoring of glycemic situations is conducted along with applicable bottom examination and care (Selvarajah et al., 2019). Likewise, the proposed change will enable people with diabetes to self-care for their diabetes and bottom by regularly changing bottom-related symptoms and seeking medical care instantly.

Financial and Health Implications 

Implementing proposed changes to prevent and manage supplemental neuropathy in people with diabetes can have significant financial and health consequences. Timely forestallment of supplemental neuropathy through proposed change can avoid the fiscal costs needed to treat supplemental neuropathy and long-term recuperation. The cost-effective early webbing, treatment, and operation reduce the fiscal burden on cases with diabetes and overall healthcare association as smaller hospitalizations, surgeries, and medical treatments (Rodríguez-Sánchez et al., 2019).

NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

This will improve quality of life, enhance glycemic control, ameliorate the prognosis, and reduce the threat of foot problems. There are colorful fiscal and health counteraccusations if the proposed changes aren’t made timely. In some cases, surgeries and medical interventions may be necessary to treat advanced supplemental neuropathy, which can create a financial burden on patients and healthcare organizations, leading to poor quality of life and reduced productivity due to impaired mobility (Kiyani et al., 2020).

Conclusion 

This summary report highlights the supplemental neuropathy issue in diabetics, a rising issue in the original healthcare systems of Colorado. For this purpose, a relative analysis of precluding and managing supplemental neuropathy in the United Kingdom and Australian healthcare systems is conducted. The findings showed that healthcare systems in Colorado could apply analogous strategies like mobile apps and supplemental neuropathy conventions to ameliorate fiscal and health issues for diabetic cases with supplemental neuropathy.

NURS FPX 6218 Assessment 1: Proposing Evidence-Based 

Change Hicks, C. W., & Selvin, E. (2019). The study focuses on the epidemiology of peripheral neuropathy and lower extremity disease in individuals with diabetes. Current Diabetes Reports, 19(10). https://doi.org/10.1007/s11892-019-1212-8 Kiyani, M., Yang, Z., Charalambous, L. T., Adil, S. M., Lee, H.-J., Yang, S., Pagadala, P., Parente, B., Spratt, S. E., & Lad, S. P. (2020). Painful diabetic peripheral neuropathy: Health care costs and complications from 2010 to 2015. Neurology: Clinical Practice, 10(1), 47–57. https://doi.org/10.1212/CPJ.0000000000000671 NICE. (2019, October 11). Overview | Diabetic foot problems: prevention and management | Guidance | NICE. https://www.nice.org.uk/guidance/ng19 Rodríguez-Sánchez, B., Peña-Longobardo, L. M., & Sinclair, A. J. (2019). Cost-effectiveness analysis of the neuropad device as a screening tool for early diabetic peripheral neuropathy. The European Journal of Health Economics, 21(3), 335–349. https://doi.org/10.1007/s10198-019-01134-2 Selvarajah, D., Kar, D., Khunti, K., Davies, M. J., Scott, A. R., Walker, J., & Tesfaye, S. (2019). Diabetic peripheral neuropathy: Advances in diagnosis and strategies for screening and early intervention. The Lancet Diabetes & Endocrinology, 7(12), 938–948. https://doi.org/10.1016/s2213-8587(19)30081-6 Zilliox, L. A., & Russell, J. W. (2019). Physical activity and dietary interventions in diabetic neuropathy: A systemic review. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society, 29(4), 443–455. https://doi.org/10.1007/s10286-019-00607-x